Brief: Oryzon Expands Patent Protection For Iadademstat With Grant Decision In Mexico

ORYZON Genomics SA

12/03/2026 07:07

March 12 (Reuters) - Oryzon Genomics SA ORY.MC:

EXPANDS PATENT PROTECTION FOR IADADEMSTAT WITH GRANT DECISION IN MEXICO COVERING COMBINATIONS WITH PD-1/PD-L1 INHIBITORS

MEXICAN PATENT OFFICE HAS ISSUED A DECISION TO GRANT FOR ITS PATENT APPLICATION ENTITLED "COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY"

FOLLOWING FORMAL GRANT, THE PATENT IS EXPECTED TO PROVIDE PROTECTION UNTIL AT LEAST 2040

ALLOWED CLAIMS PROTECT USE OF IADADEMSTAT IN COMBINATION WITH PD-1 OR PD-L1 INHIBITORS FOR TREATMENT OF CANCER, INCLUDING SMALL CELL LUNG CANCER

Source text

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))